Related Experiment Video
Updated: Sep 16, 2025

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
International Perspectives on Vitamin K Deficiency Bleeding in Infants: A Cross-Sectional Questionnaire-Based Survey
Nongnuch Sirachainan1, Patcharee Komvilaisak2, C Heleen van Ommen3
1Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Vitamin K deficiency bleeding (VKDB) remains a global concern despite prophylaxis. Key risks include lack of vitamin K at birth and liver disease, with barriers varying by country income.
Area of Science:
- Neonatal Medicine
- Pediatric Hematology
- Public Health
Background:
- Vitamin K deficiency bleeding (VKDB) poses a risk to neonates and infants due to low vitamin K transfer and storage.
- Global vitamin K (VK) prophylaxis at birth has reduced VKDB incidence, but it remains a significant concern.
Purpose of the Study:
- To assess the current incidence, risk factors, and outcomes of VKDB.
- To identify barriers and limitations to vitamin K prophylaxis worldwide.
Main Methods:
- A global survey of physicians managing VKDB or VK prophylaxis was conducted from 2021-2023.
- Responses from 685 physicians across 38 countries were analyzed using chi-square tests and hierarchical clustering.
Main Results:
- 42.1% of physicians reported treating 1-5 VKDB cases annually.
- Lack of VK at birth and liver disease were primary risk factors.
- Hierarchical clustering revealed geographical and economic disparities in risk factors and prophylaxis barriers, including parental refusal in high-income countries and limited VK availability in low-income countries.
Conclusions:
- VKDB persists globally despite prophylaxis efforts.
- Specific guidelines for infants with liver disease and enhanced parental education are crucial.
- Addressing global disparities in VK availability is essential for effective VKDB management.
Related Concept Videos
Vitamins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

